Literature DB >> 33795176

Amino Acid Depletion Therapies: Starving Cancer Cells to Death.

Miriam Butler1, Laurens T van der Meer2, Frank N van Leeuwen3.   

Abstract

Targeting tumor cell metabolism is an attractive form of therapy, as it may enhance treatment response in therapy resistant cancers as well as mitigate treatment-related toxicities by reducing the need for genotoxic agents. To meet their increased demand for biomass accumulation and energy production and to maintain redox homeostasis, tumor cells undergo profound changes in their metabolism. In addition to the diversion of glucose metabolism, this is achieved by upregulation of amino acid metabolism. Interfering with amino acid availability can be selectively lethal to tumor cells and has proven to be a cancer specific Achilles' heel. Here we review the biology behind such cancer specific amino acid dependencies and discuss how these vulnerabilities can be exploited to improve cancer therapies.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  amino acid depletion therapy; amino acid metabolism; cancer; tumor metabolism

Mesh:

Substances:

Year:  2021        PMID: 33795176     DOI: 10.1016/j.tem.2021.03.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  22 in total

1.  GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis.

Authors:  Ricardo A Cordova; Jagannath Misra; Parth H Amin; Anglea J Klunk; Nur P Damayanti; Kenneth R Carlson; Andrew J Elmendorf; Hyeong-Geug Kim; Emily T Mirek; Bennet D Elzey; Marcus J Miller; X Charlie Dong; Liang Cheng; Tracy G Anthony; Robero Pili; Ronald C Wek; Kirk A Staschke
Journal:  Elife       Date:  2022-09-15       Impact factor: 8.713

2.  NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.

Authors:  Sachin Verma; David Crawford; Ali Khateb; Yongmei Feng; Eduard Sergienko; Gaurav Pathria; Chen-Ting Ma; Steven H Olson; David Scott; Rabi Murad; Eytan Ruppin; Michael Jackson; Ze'ev A Ronai
Journal:  Nat Cell Biol       Date:  2022-09-01       Impact factor: 28.213

Review 3.  Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis.

Authors:  Yixuan Li; Shan Cao; Anastasia Gaculenko; Yifan Zhan; Aline Bozec; Xiaoxiang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-21       Impact factor: 6.055

Review 4.  A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer.

Authors:  Franklyn De Silva; Jane Alcorn
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

Review 5.  Metabolism Dysregulation in Retinal Diseases and Related Therapies.

Authors:  Yingying Chen; Nathan J Coorey; Meixia Zhang; Shaoxue Zeng; Michele C Madigan; Xinyuan Zhang; Mark C Gillies; Ling Zhu; Ting Zhang
Journal:  Antioxidants (Basel)       Date:  2022-05-11

Review 6.  Amino Acid Metabolism in Cancer Drug Resistance.

Authors:  Hee-Chan Yoo; Jung-Min Han
Journal:  Cells       Date:  2022-01-02       Impact factor: 6.600

Review 7.  Targeting Nutrient Dependency in Cancer Treatment.

Authors:  Kexin Fan; Zhan Liu; Min Gao; Kangsheng Tu; Qiuran Xu; Yilei Zhang
Journal:  Front Oncol       Date:  2022-02-01       Impact factor: 6.244

Review 8.  Metabolomics and the Multi-Omics View of Cancer.

Authors:  David Wishart
Journal:  Metabolites       Date:  2022-02-07

Review 9.  Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.

Authors:  Peter Lawrence Smith; Katarzyna Piadel; Angus George Dalgleish
Journal:  Vaccines (Basel)       Date:  2021-11-25

Review 10.  GCN2: roles in tumour development and progression.

Authors:  Lyssa T Gold; Glenn R Masson
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.